Search research articles
Contact Us
Filters
Showing results (411-420 of 706) with videos related to
Page
of 71
Sort By:
Circulation. Cardiovascular Quality and Outcomes
|
March 6, 2014
Sources of hospital-level variation in major bleeding among patients with non-st-segment elevation myocardial infarction: a report from the National Cardiovascular Data Registry (NCDR)
Ying Xian, Anita Y Chen, Laine Thomas, et al.
The American Journal of Cardiology
|
May 27, 2006
Association between blood glucose and long-term mortality in patients with acute coronary syndromes in the OPUS-TIMI 16 trial
Satish Bhadriraju, Kausik K Ray, Anthony C DeFranco, et al.
Journal of the American College of Cardiology
|
July 4, 2006
The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study
Benjamin M Scirica, Marc S Sabatine, David A Morrow, et al.
Journal of the American College of Cardiology
|
June 18, 2021
Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease
Connie N Hess, Christopher P Cannon, Joshua A Beckman, et al.
European Heart Journal. Acute Cardiovascular Care
|
December 24, 2019
Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel
Mark R Thomas, Stefan K James, Richard C Becker, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 22, 2022
Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial
David M Charytan, Jie Yu, Meg J Jardine, et al.
Clinical Cardiology
|
January 24, 2014
Quality of care for patients with acute coronary syndromes as a function of hospital revascularization capability: Insights from get with the guidelines-CAD
Arun K Thukkani, Gregg C Fonarow, Christopher P Cannon, et al.
Diabetes, Obesity & Metabolism
|
December 19, 2024
Long-term weight loss and cardiorenal outcomes by baseline BMI in the VERTIS CV trial
Francesco Cosentino, Samuel Dagogo-Jack, Robert Frederich, et al.
American Heart Journal
|
November 15, 2019
Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United States
Christopher P Cannon, James A de Lemos, Robert S Rosenson, et al.
Circulation
|
March 2, 2017
Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care)
Matthew A Cavender, William B White, Petr Jarolim, et al.
Page
of 71
Search research articles
Search
Showing results (411-420 of 706) with videos related to
Sort By:
Page
of 71
Circulation. Cardiovascular Quality and Outcomes
|
March 6, 2014
Sources of hospital-level variation in major bleeding among patients with non-st-segment elevation myocardial infarction: a report from the National Cardiovascular Data Registry (NCDR)
Ying Xian, Anita Y Chen, Laine Thomas, et al.
The American Journal of Cardiology
|
May 27, 2006
Association between blood glucose and long-term mortality in patients with acute coronary syndromes in the OPUS-TIMI 16 trial
Satish Bhadriraju, Kausik K Ray, Anthony C DeFranco, et al.
Journal of the American College of Cardiology
|
July 4, 2006
The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study
Benjamin M Scirica, Marc S Sabatine, David A Morrow, et al.
Journal of the American College of Cardiology
|
June 18, 2021
Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease
Connie N Hess, Christopher P Cannon, Joshua A Beckman, et al.
European Heart Journal. Acute Cardiovascular Care
|
December 24, 2019
Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel
Mark R Thomas, Stefan K James, Richard C Becker, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 22, 2022
Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial
David M Charytan, Jie Yu, Meg J Jardine, et al.
Clinical Cardiology
|
January 24, 2014
Quality of care for patients with acute coronary syndromes as a function of hospital revascularization capability: Insights from get with the guidelines-CAD
Arun K Thukkani, Gregg C Fonarow, Christopher P Cannon, et al.
Diabetes, Obesity & Metabolism
|
December 19, 2024
Long-term weight loss and cardiorenal outcomes by baseline BMI in the VERTIS CV trial
Francesco Cosentino, Samuel Dagogo-Jack, Robert Frederich, et al.
American Heart Journal
|
November 15, 2019
Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United States
Christopher P Cannon, James A de Lemos, Robert S Rosenson, et al.
Circulation
|
March 2, 2017
Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care)
Matthew A Cavender, William B White, Petr Jarolim, et al.
Page
of 71